Literature DB >> 24936833

An actin-binding protein espin is a growth regulator for melanoma.

Takeshi Yanagishita1, Ichiro Yajima2, Mayuko Kumasaka2, Machiko Iida2, Li Xiang3, Yasuhiko Tamada4, Yoshinari Matsumoto4, Daisuke Watanabe4, Masashi Kato5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24936833     DOI： 10.1038/jid.2014.249

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  16 in total

Review 1.  CDK inhibitors: positive and negative regulators of G1-phase progression.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1999-06-15       Impact factor: 11.361

2.  Actin-binding protein, Espin: a novel metastatic regulator for melanoma.

Authors:  Takeshi Yanagishita; Ichiro Yajima; Mayuko Kumasaka; Yoshiyuki Kawamoto; Toyonori Tsuzuki; Yoshinari Matsumoto; Daisuke Watanabe; Masashi Kato
Journal:  Mol Cancer Res       Date:  2013-12-13       Impact factor: 5.852

Review 3.  p21Cip1/Waf1 protein and its function based on a subcellular localization [corrected].

Authors:  Jana Cmielová; M Rezáčová
Journal:  J Cell Biochem       Date:  2011-12       Impact factor: 4.429

4.  Sunlight exposure-mediated DNA damage in young adults.

Authors:  Masashi Kato; Machiko Iida; Yuji Goto; Takaaki Kondo; Ichiro Yajima
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-06-15       Impact factor: 4.254

Review 5.  Espins and the actin cytoskeleton of hair cell stereocilia and sensory cell microvilli.

Authors:  G Sekerková; L Zheng; P A Loomis; E Mugnaini; J R Bartles
Journal:  Cell Mol Life Sci       Date:  2006-10       Impact factor: 9.261

6.  Espins are multifunctional actin cytoskeletal regulatory proteins in the microvilli of chemosensory and mechanosensory cells.

Authors:  Gabriella Sekerková; Lili Zheng; Patricia A Loomis; Benjarat Changyaleket; Donna S Whitlon; Enrico Mugnaini; James R Bartles
Journal:  J Neurosci       Date:  2004-06-09       Impact factor: 6.167

7.  Transgenic mouse model for skin malignant melanoma.

Authors:  M Kato; M Takahashi; A A Akhand; W Liu; Y Dai; S Shimizu; T Iwamoto; H Suzuki; I Nakashima
Journal:  Oncogene       Date:  1998-10-08       Impact factor: 9.867

8.  Roles of induced expression of MAPK phosphatase-2 in tumor development in RET-MEN2A transgenic mice.

Authors:  T Hasegawa; A Enomoto; T Kato; K Kawai; R Miyamoto; M Jijiwa; M Ichihara; M Ishida; N Asai; Y Murakumo; K Ohara; Y Niwa; H Goto; M Takahashi
Journal:  Oncogene       Date:  2008-06-09       Impact factor: 9.867

9.  A novel mouse model for de novo Melanoma.

Authors:  Mayuko Y Kumasaka; Ichiro Yajima; Khaled Hossain; Machiko Iida; Toyonori Tsuzuki; Tamio Ohno; Masahide Takahashi; Masashi Yanagisawa; Masashi Kato
Journal:  Cancer Res       Date:  2010-01-01       Impact factor: 12.701

10.  Spontaneous melanocytosis in transgenic mice.

Authors:  S Chen; H Zhu; W J Wetzel; M A Philbert
Journal:  J Invest Dermatol       Date:  1996-05       Impact factor: 8.551
View more
  1 in total

1.  An actin-binding protein ESPN is an independent prognosticator and regulates cell growth for esophageal squamous cell carcinoma.

Authors:  Shau-Hsuan Li; Hung-I Lu; Wan-Ting Huang; Yen-Hao Chen; Chien-Ming Lo; Ya-Chun Lan; Wei-Che Lin; Hsin-Ting Tsai; Chang-Han Chen
Journal:  Cancer Cell Int       Date:  2018-12-29       Impact factor: 5.722
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.